mPhase Technologies to Participate in NanoBusiness Alliance Roundtable

mPhase Technologies, Inc. (OTCBB: XDSL), the global leader in the development of nanotech-based reserve battery technology, today announced that its executives will attend the Ninth Annual NanoBusiness Alliance Washington DC Roundtable beginning March 15, 2010.

The three-day event is intended to stimulate dialogue between members of Congress, federal agency officials, and top nanotechnology industry executives. The forum provides NanoBusiness Alliance members with an opportunity to learn about new regulatory policies and federal research initiatives, and familiarize members with federal product approval authorities, processes, and innovation strategies.

Scheduled meetings include a Congressional Nanotechnology Caucus moderated by Senator Ron Wyden (D-OR), and a session with Senator Mark Pryor (D-AR), who recently introduced the Nanotechnology Safety Act of 2010. Other meetings will address sustainable development and environmental, health and safety research policies; FDA policy and guidance developments; and the Obama Administration's focus on innovation.

The NanoBusiness Alliance is the world's leading nanotechnology trade association, and was founded to advance the emerging business of nanotechnology and microsystems for corporations, start-ups, researchers, universities, investors and a host of other key stakeholders. The Alliance's mission is to create a collective voice of the emerging small tech industry and develop a range of initiatives to support and strengthen the nanotechology business community, through public policy efforts, events, research, and through the creation of partnerships.

Ron Durando, CEO of mPhase Technologies, said, "As mPhase grows, we expect to play a growing role in forging the policy directives that will shape the future of nanotechnology.This Roundtable gives us the opportunity to make our voices heard in Washington alongside much larger players. It will strengthen our influence inside the Beltway and give us a platform to advance both our own business interests and that of the field as a whole."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.